Financial News
Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma
March 09, 2023 at 07:53 AM EST
--News Direct--
Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new report on Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), following the release of selected data from its human volunteer LPS challenge trial for lead molecule POLB 001.
Contact Details
Proactive UK Ltd
+44 20 7989 0813
View source version on newsdirect.com: https://newsdirect.com/news/proactives-robin-davison-publishes-fresh-research-note-on-poolbeg-pharma-346100498
More News
View More
Whirlpool: Near-Term Pain, Long-Term Gain—Is Now the Time? ↗
Today 14:43 EST
Palantir Bulls Face a Reality Check Before Earnings ↗
Today 13:21 EST
Starbucks Gets a Jolt After Earnings, But Will the Buzz Last? ↗
Today 12:28 EST
Netflix Just Set a Hard Low—Is This The Start of a 40% Rally? ↗
Today 11:46 EST
Physical AI: The Next Industrial Revolution Is Finally Here ↗
Today 10:28 EST
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
